BioSpace News Archive

FDA

FDA Accepts Genentech’s Supplemental Biologics License Application for Tecentriq Plus Chemotherapy (Abraxane and Carboplatin) for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Tecentriq® in combination with Abraxane® and carboplatin for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not have EGFR or ALK genomic tumor aberrations.

January 17, 2019
·
11 min read
Drug Development

Targovax Granted European Patent for Mutant-RAS Neoantigen Platform Lead Products

Extends IP protection of TG01 and TG02 until 06.05.2034

January 17, 2019
·
2 min read
Drug Development

Ipsen Presents the Results of the First in-Human Study of a Recombinant Fast-Acting Neurotoxin (rBoNT-E) at TOXINS 2019

Safety, tolerability and pharmacodynamics of BoNT-E demonstrated in Phase I study

January 17, 2019
·
8 min read
Drug Development

Isofol Reports Early Tumor Shrinkage in Patients With Colorectal Cancer in Phase 1/2a Open Label Extension Study with Arfolitixorin

Isofol Medical AB (publ), announced positive results from an open-label extension study for the ISO-CC-005 Phase 1/2a study of arfolitixorin in patients with metastatic colorectal cancer (mCRC)

January 17, 2019
·
4 min read
Sectra’s Capital Markets Day--Focus on Imaging IT Solutions Business Area

International medical imaging IT and cybersecurity company Sectra (STO: SECTB) is arranging a Capital Markets Day in Linköping, Sweden.

January 17, 2019
·
3 min read
Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Gantry breakthrough on industry-leading Azurion platform opens up new imaging and patient positioning opportunities to enhance care

January 17, 2019
·
4 min read
Business

Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer

Terns Pharmaceuticals Inc., announced the appointment of Erin Quirk, M.D. as Chief Medical Officer (CMO).

January 17, 2019
·
3 min read
Sound Celebration @ Ocean Terminal Deck, Harbour City

Leading the Future of Experiential Wellness Rooted in Authenticity and Nature

January 17, 2019
·
4 min read
Business

Apollo Medical Holdings Announces The Appointment Of Linda Marsh And John Chiang To Its Board Of Directors

Apollo Medical Holdings, Inc., an integrated population health management company, today announced the appointment of Linda Marsh and John Chiang to its Board of Directors.

January 17, 2019
·
5 min read
Biotech Beach

CBD And Advanced Wellness Company, RESET Bioscience, Debuts New Product With Highest Level Of Purity And Bioavailability

RESET Bioscience, set to disrupt the current CBD market with new liposomal CBD product developed with advanced nanotechnology typically reserved for pharmaceutical giants

January 17, 2019
·
3 min read